Health
UPDATE 1-T-cell study adds to debate over duration of COVID-19 immunity – Devdiscourse
Scientists presenting the findings, from 100 non-hospitalised COVID-19 patients in Britain, said they were “reassuring” but did not mean people cannot in rare cases…
A small but key UK study has found that “cellular immunity” to the pandemic SARS-CoV-2 virus is present after six months in people who had mild or asymptomatic COVID-19 – suggesting they might have some level of protection for at least that time. Scientists presenting the findings, from 100 non-hospitalised COVID-19 patients in Britain, said they were “reassuring” but did not mean people cannot in rare cases be infected twice with the disease.
“While our findings cause us to be cautiously optimistic…
-
Business22 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 6 April 2025
-
Business22 hours agoHere’s a starter portfolio of ASX 200 shares to consider for growth, dividends, and value!
-
Noosa News22 hours agoThe Almond Ashes sees Australia and India mix business and cricket